Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_19-cv-00949/USCOURTS-cand-4_19-cv-00949-0/pdf.json

Nature of Suit Code: 367
Nature of Suit: TORTS - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause of Action: 28:1332 Diversity-Injunctive &amp; Declaratory Relief

---

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: NATIONAL PRESCRIPTION OPIATE

LITIGATION MDL No. 2804

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO í82)

On December 5, 2017, the Panel transferred 62 civil action(s) to the United States District Court for

the Northern District of Ohio for coordinated or consolidated pretrial proceedings pursuant to 28

U.S.C. § 1407. See 290 F.Supp.3d 1375 (J.P.M.L. 2017). Since that time, 1,308 additional action(s)

have been transferred to the Northern District of Ohio. With the consent of that court, all such

actions have been assigned to the Honorable Dan A. Polster.

It appears that the action(s) on this conditional transfer order involve questions of fact that are

common to the actions previously transferred to the Northern District of Ohio and assigned to Judge

Polster.

Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict

Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the

Northern District of Ohio for the reasons stated in the order of December 5, 2017, and, with the

consent of that court, assigned to the Honorable Dan A. Polster.

This order does not become effective until it is filed in the Office of the Clerk of the United States

District Court for the Northern District of Ohio. The transmittal of this order to said Clerk shall be

stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the

Panel within this 7íday period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

 Jeffery N. Lüthi

Clerk of the Panel

Mar 08, 2019

I hereby certify that this instrument is a true and correct copy of

the original on file in my office. Attest: Sandy Opacich, Clerk

U.S. District Court, Northern District of Ohio

By: /s/Robert Pitts

Deputy Clerk

Case 4:19-cv-00949-DMR Document 9 Filed 03/08/19 Page 1 of 3
IN RE: NATIONAL PRESCRIPTION OPIATE

LITIGATION MDL No. 2804

SCHEDULE CTOí82 í TAGíALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

ARIZONA

AZ 3 19í08048 Mohave, County of v. Purdue Pharma LP et al

CALIFORNIA CENTRAL

CAC 2 19í01186 County of Santa Barbara et al v. Purdue Pharma, L.P. et

al

CALIFORNIA NORTHERN

CAN 4 19í00949 County of San Mateo v. Purdue Pharma L.P. et al

FLORIDA SOUTHERN

FLS 0 19í60431 The City of Hallandale Beach, Florida v. Purdue Pharma

L.P. et al

FLS 0 19í60472 The City of Lauderhill, Florida v. Purdue Pharma L.P. et

al

FLS 1 19í20618 Miccosukee Tribe of Indians of Florida v.

AmerisourceBergen Drug Corporation et al

GEORGIA SOUTHERN

GAS 5 19í00016 Atkinson County, Georgia v. Purdue Pharma L.P. et al

LOUISIANA EASTERN

LAE 2 19í01594 Newman et al v. Purdue Pharma LP et al

MASSACHUSETTS

MA 1 19í10292 Town of Provincetown v. Amerisourcebergen Drug

Corporation et al

MA 1 19í10302 Town of Dennis v. Amerisourcebergen Drug

Corporation et al

MICHIGAN EASTERN

Case 4:19-cv-00949-DMR Document 9 Filed 03/08/19 Page 2 of 3
MIE 2 19í10488 Flint, City of v. ACTAVIS PHARMA, INC. f/k/a

WATSON PHARMA, INC. et al

OKLAHOMA WESTERN

OKW 5 19í00149 Edmond City of v. Purdue Pharma LP et al

OKW 5 19í00158 Guthrie City of v. Purdue Pharma LP et al

OKW 5 19í00160 Ponca City City of v. Purdue Pharma LP et al

Opposed 3/6/19

Opposed 3/6/19

Opposed 3/6/19

Case 4:19-cv-00949-DMR Document 9 Filed 03/08/19 Page 3 of 3